4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-14-002287
CIK 0001316175operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:57 PM ET
Size
9.7 KB
Accession
0001214659-14-002287
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Award
Common Stock
2014-03-25−3,864→ 10,465 total - Award
Stock option (right to buy)
2014-03-25+10,070→ 10,070 totalExercise: $3.30From: 2014-03-25Exp: 2024-03-25→ Common Stock (10,070 underlying) - Tax Payment
Common Stock
2014-03-25$3.30/sh−2,783$9,184→ 6,601 total
Holdings
- 12,491(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 6,190 performance shares, which represent the portion of the Reporting Person?s 2012 performance share award.
- [F2]Shares have been adjusted to reflect the issuer?s 1-for-8 reverse split effectuated on July 15, 2013.
- [F3]Award of Restricted Stock Units under the issuer?s 2013 Stock Option and Incentive Plan that vest immediately on 03/25/2014.
- [F4]Not applicable.
- [F5]The stock option vests immediately on 03/25/2014.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 9:57 PM ET
- Size
- 9.7 KB